Nom du produit:N-[(1S,2R,3E)-1-[(β-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-hexanamide
IUPAC Name:N-[(2S,3R,4E)-3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide
- CAS：170212-26-7
- Formule moléculaire：C36H59N5O11
- Pureté：95%+
- Numéro de catalogue：CM573150
- Poids moléculaire：737.89
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:170212-26-7
- Formule moléculaire:C36H59N5O11
- Point de fusion:-
- Code SMILES:CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCNC1=CC=C(C2=NON=C12)[N+]([O-])=O
- Densité:
- Numéro de catalogue:CM573150
- Poids moléculaire:737.89
- Point d'ébullition:
- N° Mdl:MFCD03453619
- Stockage:
Category Infos
- Benzofurazans
- Benzofurazans are important pharmaceutical intermediates. Benzofurazans are known bioisosteres of the nitro group. Both oxadiazoles and nitro groups have strong electron-withdrawing properties, but when optimizing drug-like properties such as activity, selectivity, and stability, the absence of standard charges in the oxadiazole structure may be more beneficial to drug products. What's more, nitro groups have been identified as toxic groups, and it is routine to remove or replace them in the early stages of drug development.
Recherche 
+86 21 5895 0110 
